Education
About Us
Working with TipRanks
Follow Us
Definitive Healthcare Corp (DH)
NASDAQ:DH
RESEARCH TOOLSreports
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.05Last Year’s EPS
0.09Same Quarter Last Year
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: 33.81%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial execution and operational improvements, particularly in data integration and strategic partnerships. However, there were notable challenges including a year-over-year revenue decline and pressures in the life sciences segment. The sentiment reflects a cautious optimism as the company works through these challenges while showing signs of stabilization and strategic progress.Company Guidance
During the Q1 2025 earnings call, Definitive Healthcare Corp. provided guidance that exceeded expectations, with total revenue reaching $59.2 million, down 7% year-over-year, but surpassing the high end of their guidance due to strong professional services and in-period subscription revenue. Adjusted EBITDA was significantly above expectations at $14.7 million, representing a 25% margin. The company also reported a 91% conversion from adjusted EBITDA to unlevered free cash flow over the trailing twelve months. Despite lower retention rates, the company observed stabilization in renewal rates and highlighted new logo activity across all end markets. For Q2 2025, they projected revenue between $58.5 and $60 million, with an adjusted EBITDA margin of 25% to 27%. For the full year, they tightened revenue guidance to $234 million to $240 million, aiming for an adjusted EBITDA margin of 26% to 28%. The company remains focused on improving retention, leveraging differentiated data, seamless data integration, and customer success, while navigating macroeconomic uncertainties.Exceeded Q1 Financial Guidance
Total revenue for Q1 2025 was $59.2 million, which exceeded the high end of the guidance range, largely due to outperformance in professional services and in-period subscription revenue.
Strong Adjusted EBITDA
Adjusted EBITDA for Q1 was $14.7 million, representing a 25% margin, and was well ahead of expectations.
Operational Improvements
The company has made significant progress in stabilizing renewal rates and achieving strong new logo wins across all end markets.
Successful Data Integration
The company saw strong double-digit growth in customer engagements that integrated Definitive's data with their systems, leading to higher retention rates.
Strategic Partnerships
Expansion of go-to-market reach with healthcare advertising agencies and direct deals, expected to drive momentum in the second half of 2025.
DH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $2.81 | $3.69 | +31.32% |
Feb 27, 2025 | $4.92 | $3.23 | -34.35% |
Nov 07, 2024 | $4.31 | $4.24 | -1.62% |
Aug 05, 2024 | $3.55 | $3.65 | +2.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Definitive Healthcare Corp (DH) report earnings?
Definitive Healthcare Corp (DH) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Definitive Healthcare Corp (DH) earnings time?
Definitive Healthcare Corp (DH) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DH EPS forecast?
DH EPS forecast for the fiscal quarter 2025 (Q2) is 0.05.